MRI Scan for Arthritis: Joint Assessment

Arthritis affects over 10 million people in the UK. It is not one condition but a group of over 100 different diseases that cause joint pain, stiffness, and inflammation. MRI is the most sensitive imaging tool for detecting early arthritis — it can show cartilage damage, bone marrow changes, synovitis (joint lining inflammation), and erosions months or years before they appear on X-ray.

Whether you have a single swollen joint, multiple painful joints, or stiffness that is worse in the morning, an MRI can help identify the type of arthritis you have, how advanced it is, and which treatment approach is most appropriate.

Types of Arthritis That MRI Can Detect

Osteoarthritis (OA)

The most common type, affecting around 8.75 million people in the UK. Caused by wear of the articular cartilage that cushions joint surfaces. Knees, hips, hands, and spine are most commonly affected. MRI shows:

• Cartilage thinning, fissuring, and full-thickness loss (graded using the MOAKS or Outerbridge scoring systems)
• Subchondral bone marrow oedema (bone bruising) — often correlates with pain
• Osteophytes (bone spurs)
• Subchondral cysts
• Synovitis and joint effusion (more common in OA than previously thought)
• Meniscal tears and ligament degeneration (in knee OA)

MRI detects OA changes years before X-ray does. X-ray only shows joint space narrowing once cartilage loss is significant, while MRI can visualise early cartilage softening and bone marrow changes.

Rheumatoid Arthritis (RA)

An autoimmune condition affecting around 400,000 people in the UK. The immune system attacks the synovium (joint lining), causing inflammation, cartilage destruction, and bone erosion. Typically affects small joints of the hands and feet symmetrically. MRI shows:

• Synovitis — thickened, enhancing synovium on contrast-enhanced MRI. MRI detects synovitis before it is clinically apparent.
• Bone erosions — MRI detects erosions 2-5 years earlier than X-ray. Small erosions visible on MRI may be missed on X-ray until they enlarge.
• Bone marrow oedema — often precedes erosion formation and is considered a predictor of future joint damage.
• Tenosynovitis — inflammation of tendon sheaths, common in RA.
• Joint effusions

The RAMRIS (Rheumatoid Arthritis MRI Scoring) system is used internationally to standardise MRI assessment and monitor treatment response in RA.

Psoriatic Arthritis (PsA)

Affects up to 30% of people with psoriasis. Can affect any joint but has characteristic features on MRI including enthesitis (inflammation where tendons attach to bone), dactylitis (sausage-like swelling of entire fingers/toes), and pencil-in-cup erosions.

Ankylosing Spondylitis (AS)

An inflammatory arthritis primarily affecting the spine and sacroiliac joints. Affects around 1 in 200 people in the UK, typically starting before age 45. MRI of the sacroiliac joints is key for early diagnosis — showing bone marrow oedema (active inflammation) and structural changes (erosions, fatty change, sclerosis, ankylosis). MRI can detect sacroiliitis years before X-ray changes develop, dramatically shortening the diagnostic delay that historically averaged 8-10 years.

Gout

Caused by urate crystal deposition in joints. Affects about 2.5% of UK adults. MRI can show joint effusion, synovitis, bone erosions, and soft tissue tophi (crystal deposits), though dual-energy CT (DECT) is increasingly preferred for gout-specific diagnosis.

Which MRI Scan Do You Need for Arthritis?

The scan depends on which joints are affected:

• Knee arthritis — knee MRI (from £275). Shows cartilage, menisci, ligaments, and bone detail.
• Hip arthritis — hip MRI (from £249). Shows cartilage, labrum, and avascular necrosis.
• Shoulder arthritis — shoulder MRI (from £275). Shows glenohumeral and AC joint disease.
• Hand/wrist arthritis — hand or wrist MRI (from £275). Critical for early RA diagnosis.
• Spinal arthritis — lumbar (from £275) or cervical (from £275) spine MRI.
• Sacroiliac joints (ankylosing spondylitis) — pelvis MRI (from £275) with dedicated sacroiliac joint protocol.
• Foot/ankle arthritis — foot/ankle MRI (from £249).

What MRI Cannot Show

• The specific diagnosis — MRI shows patterns of joint damage and inflammation, but the specific type of arthritis is diagnosed by combining MRI findings with blood tests (RF, anti-CCP, HLA-B27, urate), clinical examination, and history.
• Pain severity — MRI findings do not always correlate with pain levels. Some people with severe MRI changes have mild symptoms, and vice versa.
• Response to treatment (without comparison) — a single MRI cannot show whether treatment is working. Serial scans (baseline and follow-up) are needed to assess change over time.

What to Expect During the Scan

Scan duration depends on the joint: knee 25-35 minutes, hip 25-35 minutes, hand/wrist 30-40 minutes, pelvis/SI joints 25-35 minutes. Positioning varies by joint. No special preparation is needed for most arthritis MRI scans unless contrast is being used.

Alternative Diagnostic Approaches

• X-ray — first-line for suspected OA. Shows joint space narrowing, osteophytes, and subchondral sclerosis. Insensitive to early disease. Still the standard for monitoring RA erosions alongside MRI.
• Ultrasound — excellent for detecting synovitis, joint effusions, and erosions in superficial joints (hands, wrists, feet). Can be used with power Doppler to assess active inflammation. Less useful for deep joints (hip, spine).
• CT — better than MRI for bony detail. DECT is specifically useful for gout diagnosis.
• Blood tests — rheumatoid factor (RF), anti-CCP antibodies, HLA-B27, ESR, CRP, uric acid, full blood count. Essential for arthritis diagnosis and classification.
• Joint aspiration — removing fluid from a swollen joint for crystal analysis (gout, pseudogout), infection testing, or cell count. The only way to definitively diagnose crystal arthritis.

Treatment Pathways

• Osteoarthritis — weight management, physiotherapy, regular exercise, NSAIDs, topical treatments. Joint injections (steroid, hyaluronic acid). Joint replacement surgery for severe, end-stage disease (knee: around 100,000/year in UK; hip: around 90,000/year).
• Rheumatoid arthritis — early aggressive treatment with disease-modifying antirheumatic drugs (DMARDs). Methotrexate is first-line. Biologic therapies (anti-TNF, rituximab, tocilizumab) for patients not responding to conventional DMARDs. The target is remission or low disease activity. Early treatment prevents joint damage — hence the importance of early MRI detection.
• Ankylosing spondylitis — NSAIDs (first-line, often highly effective), physiotherapy (essential for maintaining spinal mobility), biologic therapies (anti-TNF, IL-17 inhibitors) for patients not responding to NSAIDs.
• Psoriatic arthritis — DMARDs, biologic therapies, management of skin and joint disease together.
• Gout — acute: colchicine, NSAIDs, corticosteroids. Long-term: urate-lowering therapy (allopurinol, febuxostat) to prevent attacks and joint damage. Target serum urate below 300 µmol/L.

UK Statistics

• Over 10 million people in the UK have arthritis
• Osteoarthritis: around 8.75 million affected
• Rheumatoid arthritis: approximately 400,000 affected
• Ankylosing spondylitis: approximately 200,000 affected
• Gout: approximately 1.6 million affected (2.5% of adults)
• Arthritis is the leading cause of disability in the UK
• Around 190,000 joint replacement operations are performed annually in the UK

Frequently Asked Questions

Related Blood Tests

• CRP and ESR — inflammation markers
• Rheumatoid factor (RF) and anti-CCP — for rheumatoid arthritis
• HLA-B27 — for ankylosing spondylitis
• Uric acid — for gout
• Full blood count — can show anaemia of chronic disease

Browse Lola Health blood tests

Related Articles

• MRI Scan for Knee Pain
• MRI Scan for Hip Pain
• MRI Scan for Shoulder Pain
• MRI Scan for Back Pain
• Avascular Necrosis MRI